Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, KSA) and Prof Nick Curzen (University Hospital Southampton NHS Trust, Southampton, UK) discuss the design, outcomes, economic implications of the FORECAST late-breaking trial. 

Recorded remotely from Jeddah and Southampton, 2020. 

Recording Editors: Natascha Wienand, Tom Green
Editor: Mirjam Boros